Healthcare & Life Sciences
Pharmability
Sweden
About
Pharmability (formerly TIRmed) develops next-generation targeted therapies for atopic dermatitis by addressing the root causes of the disease to provide effective and long-lasting relief.
Explore Pharmability's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.